A new, highly active Ni-La 2 O 3 /SBA-15(C) catalyst for CO 2 methanation was prepared using a citrate complex method, where the formed LaNiO 3 with perovskite structure was a key precursor. The physicochemical properties of the catalyst, as-prepared and spent, and its catalytic performance were analyzed in detail and compared with catalysts prepared through a typical wet impregnation method. 10 wt % nickel with lanthanum in the molar ratio of 1:1 was used to prepare the La-modified catalysts. It was found that the La 2 O 3 doping methods had a noticeable effect on the structures of the catalysts and their catalytic performances. Ni-La 2 O 3 /SBA-15(C) showed a high dispersion of Ni with a small particle size less than 5 nm, which is one-third of the particle size of that prepared by impregnation. Decent catalytic performance was achieved with a CO 2 conversion of 90.7% and CH 4 selectivity of 99.5% at 320 °C. Due to the specific perovskite structure of LaNiO 3, the interaction between La and Ni was intensified, thus enhancing the synergistic effect of La 2 O 3 and Ni, which contributed to the high dispersion of Ni nanoparticles as well as the good antisintering and anticarbon deposition properties. Density functional theory calculations also suggested that the catalyst derived from LaNiO 3 favored the adsorption and activation of CO 2 and facilitated further hydrogenation. This work provides an effective strategy to develop highly active and stable catalysts for CO 2 methanation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: